Efficacy and safety of treatment with direct acting antiviral (s) in Chronic Hepatitis C (CHC) patients with compensated advanced liver disease and signs of portal hypertension. HERACLIS: a Hellenic multicenter real-life cohort clinical study

Citation:

Vlachogiannakos J, Manolakopoulos S, Samonakis DN, Koskinas J, Papageorgiou M-V, Ketikoglou I, Oikonomopoulou M, Elefsiniotis IS, Goulis I, Vasileiadis TG, et al. Efficacy and safety of treatment with direct acting antiviral (s) in Chronic Hepatitis C (CHC) patients with compensated advanced liver disease and signs of portal hypertension. HERACLIS: a Hellenic multicenter real-life cohort clinical study. In: HEPATOLOGY. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 813A–814A. Copy at http://www.tinyurl.com/ytlasd7k